{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:32:01Z","timestamp":1794047521168,"version":"4.8.0"},"reference-count":50,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>In 20-30% of severe hemophilia A (HA) patients, FVIII replacement therapy is hindered by inhibitory antibodies. Nonsense mutations in the FVIII light chain (A3-C1-C2) carry a higher risk of inhibitor formation than those in the heavy chain (A1-A2-B). The underlying molecular mechanism remains unclear. Using induced pluripotent stem (iPS) cells from HA patients, we developed two types of endothelial cell models, induced lymphatic endothelial cells (iLEC) and induced liver sinusoidal endothelial cells (iLSEC), that mimic native F8 mRNA expression and protein synthesis. Immunoassays detected FVIII protein in wild-type, intron 22 inversions (I22I), and two high inhibitor risk light chain variants (R1960X, R2228X). Co-staining with ER markers (PDI, BiP) revealed differential processing: R1960X exhibit enhanced proteasomal degradation with SEL1L, essential for MHC-I peptide loading, possibly contributing to higher immunogenicity. In contrast, R2228X showed a pattern more similar to wild-type, suggesting partial secretory potential. Although a mild co-localization with SEL1L was observed, it was not significant. Clinically, this patient did not develop inhibitors. In addition, exploratory in silico peptide binding predictions suggested that R1960X may generate a higher number of FVIII-derived epitopes presented via patient-specific HLA alleles compared to R2228X, further supporting differential immunogenicity. The I22I variant also showed detectable FVIII protein, which was deglycosylated and retained in the ER but did not co-localize with SEL1L; no inhibitor was observed in this case either. This cellular model shows reduced variability compared to primary cells, enabling patient-specific FVIII variant analyses, including intracellular processing, within the genetic background of the individual patient.<\/jats:p>","DOI":"10.3324\/haematol.2025.288250","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T09:14:08Z","timestamp":1764234848000},"page":"1289-1303","source":"Crossref","is-referenced-by-count":1,"title":["Divergent processing of FVIII light chain variants: secretory potential &lt;i&gt;versus&lt;\/i&gt; proteasomal retention"],"prefix":"10.3324","volume":"111","author":[{"given":"Heike","family":"Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin J.","family":"Czogalla-Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pujan","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Forin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Feist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Pezeshkpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawya","family":"Al-Rifai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"El-Maarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"87724","doi-asserted-by":"crossref","unstructured":"Franchini M, Mannucci PM. Past, present and future of hemophilia: a narrative review. Orphanet J Rare Dis. 2012; 7:24.","DOI":"10.1186\/1750-1172-7-24"},{"key":"87725","doi-asserted-by":"crossref","unstructured":"Garagiola I, Palla R, Peyvandi F. Risk factors for inhibitor development in severe hemophilia a. Thromb Res. 2018; 168:20-27.","DOI":"10.1016\/j.thromres.2018.05.027"},{"key":"87726","doi-asserted-by":"crossref","unstructured":"Oldenburg J, Pavlova A. Genetic risk factors for inhibitors to factors VIII and IX. Haemophilia. 2006; 12(6):15-22.","DOI":"10.1111\/j.1365-2516.2006.01361.x"},{"key":"87727","doi-asserted-by":"crossref","unstructured":"Astermark J, Oldenburg J, Carlson J. Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A. Blood. 2006; 108(12):3739-3745.","DOI":"10.1182\/blood-2006-05-024711"},{"key":"87728","doi-asserted-by":"crossref","unstructured":"Astermark J, Oldenburg J, Pavlova A, Berntorp E, Lefvert AK, Group MS. Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A. Blood. 2006; 107(8):3167-3172.","DOI":"10.1182\/blood-2005-09-3918"},{"key":"87729","doi-asserted-by":"crossref","unstructured":"Astermark J, Wang X, Oldenburg J, Berntorp E, Lefvert AK, Group MS. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A. J Thromb Haemost. 2007; 5(2):263-265.","DOI":"10.1111\/j.1538-7836.2007.02290.x"},{"key":"87730","doi-asserted-by":"crossref","unstructured":"David D, Santos IM, Johnson K, Tuddenham EGD, McVey JH. Analysis of the consequences of premature termination codons within factor VIII coding sequences. J Thromb Haemost. 2003; 1(1):139-146.","DOI":"10.1046\/j.1538-7836.2003.00013.x"},{"key":"87731","doi-asserted-by":"crossref","unstructured":"Gouw SC, van den Berg HM, Oldenburg J. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis. Blood. 2012; 119(12):2922-2934.","DOI":"10.1182\/blood-2011-09-379453"},{"key":"87732","doi-asserted-by":"crossref","unstructured":"Testa MF, Lombardi S, Bernardi F. Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association. Haematologica. 2023; 108(2):472-482.","DOI":"10.3324\/haematol.2022.281279"},{"key":"87733","doi-asserted-by":"crossref","unstructured":"Pandey GS, Yanover C, Miller-Jenkins LM. Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A. Nat Med. 2013; 19(10):1318-1324.","DOI":"10.1038\/nm.3270"},{"key":"87734","doi-asserted-by":"crossref","unstructured":"Vir P, Gunasekera D, Dorjbal B. Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk. J Thromb Haemost. 2024; 22(12):3415-3430.","DOI":"10.1016\/j.jtha.2024.08.007"},{"key":"87735","doi-asserted-by":"crossref","unstructured":"Bernabeu-Herrero ME, Patel D, Bielowka A. Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT. Blood. 2024; 143(22):2314-2331.","DOI":"10.1182\/blood.2023021777"},{"key":"87736","doi-asserted-by":"crossref","unstructured":"Pan J, Dinh TT, Rajaraman A. Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo. Blood. 2016; 128(1):104-109.","DOI":"10.1182\/blood-2015-12-684688"},{"key":"87737","doi-asserted-by":"crossref","unstructured":"Jacquemin M, Neyrinck A, Hermanns MI. FVIII production by human lung microvascular endothelial cells. Blood. 2006; 108(2):515-517.","DOI":"10.1182\/blood-2005-11-4571"},{"key":"87738","doi-asserted-by":"crossref","unstructured":"Shahani T, Lavend\u2019homme R, Luttun A, Saint-Remy JM, Peerlinck K, Jacquemin M. Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool. Blood. 2010; 115(23):4902-4909.","DOI":"10.1182\/blood-2009-07-232546"},{"key":"87739","doi-asserted-by":"crossref","unstructured":"Koch PS, Lee KH, Goerdt S, Augustin HG. Angiodiversity and organotypic functions of sinusoidal endothelial cells. Angiogenesis. 2021; 24(2):289-310.","DOI":"10.1007\/s10456-021-09780-y"},{"key":"87740","doi-asserted-by":"crossref","unstructured":"Gage BK, Liu JC, Innes BT. Generation of functional liver sinusoidal endothelial cells from human pluripotent stem-cell-derived venous angioblasts. Cell Stem Cell. 2020; 27(2):254-269.e259.","DOI":"10.1016\/j.stem.2020.06.007"},{"key":"87741","doi-asserted-by":"crossref","unstructured":"Koui Y, Kido T, Ito T. An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells. Stem Cell Rep. 2017; 9(2):490-498.","DOI":"10.1016\/j.stemcr.2017.06.010"},{"key":"87742","doi-asserted-by":"crossref","unstructured":"Jamil MA, Singer H, Al-Rifai R. Molecular analysis of fetal and adult primary human liver sinusoidal endothelial cells: a comparison to other endothelial cells. Int J Mol Sci. 2020; 21(20):7776.","DOI":"10.3390\/ijms21207776"},{"key":"87743","doi-asserted-by":"crossref","unstructured":"Patsch C, Challet-Meylan L, Thoma EC. Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nat Cell Biol. 2015; 17(8):994-1003.","DOI":"10.1038\/ncb3205"},{"key":"87744","doi-asserted-by":"crossref","unstructured":"Fahs SA HM, Shi Q, Weiler H, Montgomery RR. A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII. Blood. 2014; 123(24):3706-3713.","DOI":"10.1182\/blood-2014-02-555151"},{"key":"87745","doi-asserted-by":"crossref","unstructured":"Arai T, Sakurai T, Kamiyoshi A. Induction of LYVE-1\/ stabilin-2-positive liver sinusoidal endothelial-like cells from embryoid bodies by modulation of adrenomedullin-RAMP2 signaling. Peptides. 2011; 32(9):1855-1865.","DOI":"10.1016\/j.peptides.2011.07.005"},{"key":"87746","doi-asserted-by":"crossref","unstructured":"Hen G, Nicenboim J, Mayseless O. Venous-derived angioblasts generate organ-specific vessels during zebrafish embryonic development. Development. 2015; 142(24):4266-4278.","DOI":"10.1242\/dev.129247"},{"key":"87747","doi-asserted-by":"crossref","unstructured":"Zhang H, Pu W, Tian X. Genetic lineage tracing identifies endocardial origin of liver vasculature. Nat Genet. 2016; 48(5):537-543.","DOI":"10.1038\/ng.3536"},{"key":"87748","doi-asserted-by":"crossref","unstructured":"Hough C, Notley C, Mo A, Videl B, Lillicrap D. Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cells. J Thromb Haemost. 2022; 20(11):2507-2518.","DOI":"10.1111\/jth.15841"},{"key":"87749","doi-asserted-by":"crossref","unstructured":"Shahani T, Covens K, Lavend\u2019homme R. Human liver sinusoidal endothelial cells but not hepatocytes contain FVIII. J Thromb Haemost. 2014; 12(1):36-42.","DOI":"10.1111\/jth.12412"},{"key":"87750","doi-asserted-by":"crossref","unstructured":"Lee SJ, Park C, Lee JY. Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair. Sci Rep. 2015; 5:11019.","DOI":"10.1038\/srep11019"},{"key":"87751","unstructured":"Rufaihah AJ, Huang NF, Kim J. Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity. Am J Transl Res. 2013; 5(1):21-35."},{"key":"87752","doi-asserted-by":"crossref","unstructured":"Flister MJ, Wilber A, Hall KL. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood. 2010; 115(2):418-429.","DOI":"10.1182\/blood-2008-12-196840"},{"key":"87753","doi-asserted-by":"crossref","unstructured":"Johnson LA, Prevo R, Clasper S, Jackson DG. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem. 2007; 282(46):33671-33680.","DOI":"10.1074\/jbc.M702889200"},{"key":"87754","doi-asserted-by":"crossref","unstructured":"Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 1994; 265(5168):106-109.","DOI":"10.1126\/science.8016643"},{"key":"87755","doi-asserted-by":"crossref","unstructured":"Ditadi A, Sturgeon CM. Directed differentiation of definitive hemogenic endothelium and hematopoietic progenitors from human pluripotent stem cells. Methods. 2016; 101:65-72.","DOI":"10.1016\/j.ymeth.2015.10.001"},{"key":"87756","doi-asserted-by":"crossref","unstructured":"MacParland SA, Liu JC, Ma XZ. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun. 2018; 9(1):4383.","DOI":"10.1038\/s41467-018-06318-7"},{"key":"87757","doi-asserted-by":"crossref","unstructured":"Scarfo R, Randolph LN, Abou Alezz M. CD32 captures committed haemogenic endothelial cells during human embryonic development. Nat Cell Biol. 2024; 26(5):719-730.","DOI":"10.1038\/s41556-024-01403-0"},{"key":"87758","doi-asserted-by":"crossref","unstructured":"Madoiwa S, Yamauchi T, Kobayashi E. Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A. J Thromb Haemost. 2009; 7(5):811-824.","DOI":"10.1111\/j.1538-7836.2009.03314.x"},{"key":"87759","doi-asserted-by":"crossref","unstructured":"Meunier S, Menier C, Marcon E, Lacroix-Desmazes S, Maillere B. CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise naive and memory cells. Blood Adv. 2017; 1(21):1842-1847.","DOI":"10.1182\/bloodadvances.2017008706"},{"key":"87760","doi-asserted-by":"crossref","unstructured":"Porcheddu V, Lhomme G, Giraudet R, Correia E, Maillere B. The self-reactive FVIII T cell repertoire in healthy individuals relies on a short set of epitopes and public clonotypes. Front Immunol. 2024; 15:1345195.","DOI":"10.3389\/fimmu.2024.1345195"},{"key":"87761","doi-asserted-by":"crossref","unstructured":"Rouhani SJ, Eccles JD, Tewalt EF, Engelhard VH. Regulation of T-cell tolerance by lymphatic endothelial cells. J Clin Cell Immunol. 2014; 5:1000242.","DOI":"10.4172\/2155-9899.1000242"},{"key":"87762","doi-asserted-by":"crossref","unstructured":"Dubrot J, Duraes FV, Potin L. Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4(+) T cell tolerance. J Exp Med. 2014; 211(6):1153-1166.","DOI":"10.1084\/jem.20132000"},{"key":"87763","doi-asserted-by":"crossref","unstructured":"Knolle PA, Wohlleber D. Immunological functions of liver sinusoidal endothelial cells. Cell Mol Immunol. 2016; 13(3):347-353.","DOI":"10.1038\/cmi.2016.5"},{"key":"87764","doi-asserted-by":"crossref","unstructured":"Xu X, Jin R, Li M. Liver sinusoidal endothelial cells induce tolerance of autoreactive CD4+ recent thymic emigrants. Sci Rep. 2016; 6:19861.","DOI":"10.1038\/srep19861"},{"key":"87765","doi-asserted-by":"crossref","unstructured":"ten Broeke T, Wubbolts R, Stoorvogel W. MHC class II antigen presentation by dendritic cells regulated through endosomal sorting. Cold Spring Harb Perspect Biol. 2013; 5(12)","DOI":"10.1101\/cshperspect.a016873"},{"key":"87766","doi-asserted-by":"crossref","unstructured":"Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu Rev Immunol. 2013; 31:443-473.","DOI":"10.1146\/annurev-immunol-032712-095910"},{"key":"87767","doi-asserted-by":"crossref","unstructured":"Berner N, Reutter KR, Wolf DH. Protein quality control of the endoplasmic reticulum and ubiquitin-proteasome-triggered degradation of aberrant proteins: yeast pioneers the path. Annu Rev Biochem. 2018; 87:751-782.","DOI":"10.1146\/annurev-biochem-062917-012749"},{"key":"87768","doi-asserted-by":"crossref","unstructured":"Christianson JC, Ye Y. Cleaning up in the endoplasmic reticulum: ubiquitin in charge. Nat Struct Mol Biol. 2014; 21(4):325-335.","DOI":"10.1038\/nsmb.2793"},{"key":"87769","doi-asserted-by":"crossref","unstructured":"Mueller B, Lilley BN, Ploegh HL. SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ER. J Cell Biol. 2006; 175(2):261-270.","DOI":"10.1083\/jcb.200605196"},{"key":"87770","doi-asserted-by":"crossref","unstructured":"Wang YM, Alexander SI. CD8 regulatory T cells: what\u2019s old is now new. Immunol Cell Biol. 2009; 87(3):192-193.","DOI":"10.1038\/icb.2009.8"},{"key":"87771","doi-asserted-by":"crossref","unstructured":"Jiang H, Wu Y, Liang B. An affinity\/avidity model of peripheral T cell regulation. J Clin Invest. 2005; 115(2):302-312.","DOI":"10.1172\/JCI23879"},{"key":"87772","doi-asserted-by":"crossref","unstructured":"Jiang H, Chess L. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Annu Rev Immunol. 2000; 18:185-216.","DOI":"10.1146\/annurev.immunol.18.1.185"},{"key":"87773","unstructured":"So JS. Roles of endoplasmic reticulum stress in immune responses. Mol Cells. 2018; 41(8):705-716."}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/13018\/79158","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/13018\/79865","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/13018\/79158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:10:26Z","timestamp":1794046226000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/13018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2025.288250","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,27]]}}}